Axial Biotherapeutics raises $25M in series b financing

Axial Biotherapeutics, a biotechnology company building a unique class of gut-targeted programs for neurodegenerative an...

February 28, 2019 | Thursday | News
The CoWrks Foundry partners with Yale University

To address growing health and social disparities in India and around the globe, The CoWrks Foundry has partnered with Ya...

February 28, 2019 | Thursday | News
Bausch Health to acquire assets of Synergy Pharma

Bausch Health Companies Inc. has announced that the Company was selected as the successful bidder to acquire certain ass...

February 27, 2019 | Wednesday | News
Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes ...

February 26, 2019 | Tuesday | News
HOOKIPA Pharma raises $37.4M in Series D Financing

HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infect...

February 26, 2019 | Tuesday | News
Marinomed receives EUR 15M EIB financing

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutica...

February 26, 2019 | Tuesday | News
FDA & Flatiron Health expand Data Cancer Research collaboration

Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Admini...

February 27, 2019 | Wednesday | News
Novartis to license Akcea-Ionis cardiac disease drug

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to licen...

February 26, 2019 | Tuesday | News
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...

February 25, 2019 | Monday | News
GE to sell Biopharma business for $21.4B to Danaher

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration ...

February 26, 2019 | Tuesday | News
Sysmex Inostics’ OncoBEAM shows superior performance in mutation detection for HCC

Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitiv...

February 25, 2019 | Monday | News
EC approves Pfizer's ZIRABEV, a biosimilar to Avastin

Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic ca...

February 25, 2019 | Monday | News
Roche to acquire Spark Therapeutics for $ 4.3B

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeuti...

February 25, 2019 | Monday | News
AbbVie and Voyager Therapeutics announce collaboration

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing ...

February 25, 2019 | Monday | News
FDA grants priority review to Merck’s application for KEYTRUDA in SCLC

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supp...

February 22, 2019 | Friday | News
Teva to apply Insilico’s predictive Digital Twins for biopharmaceutical production

Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. have announced an agreement to apply Insilico’s ...

February 22, 2019 | Friday | News
WHO releases report on Global Health Expenditure

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic pr...

February 22, 2019 | Friday | News
Merck to acquire Immune Design in a $300M deal

Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have ente...

February 22, 2019 | Friday | News